Sign in
4

Changes in Ownership

Edwards Lifesciences Corp Filed Acc 0001225208-25-001709

Director sold 5,739 shares at $75.86 ($435,371)

  • Director acquired 5,739 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

STONE HEISZ LESLIE · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-02-13 Exercise or conversion : show line 1 in the form +5,739 $45.32 $260,073 35,774 D
2025-02-13 Sale : show line 2 in the form −5,739 $75.86 $435,371 30,035 D
Open-market sales · 5,739 sh · avg $75.86 · $435,371

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-02-13 Exercise or conversion : show line 3 in the form Director Stock Option (Right to Acquire) −5,739 0 D
Loading xslF345X05/doc4.xml…